当前位置: 首页 > 期刊 > 《医学信息》 > 2015年第49期
编号:12778902
非小细胞肺癌不同剂量同步放化疗的临床观察与分析(2)
http://www.100md.com 2015年12月10日 医学信息 2015年第49期
     [1]Baum annm,Appolds,pe Terson c,et al dose and fractionation concepts in the primary radiotherapy of non small cell lung cancer[J].lung cancer,2001,33:s43-45.

    [2]Sause W,Kolesar P,Taylor S,et al.Final results of phase HI trial in regionallyadvanced unresectable non-small ccll lung cancer-Radiation Therapy OncologyGroup,Eastern Cooperative Oncology Group,and Southwest Oncology Group[J].Chest,2000,117:358-364.

    [3]Guida C,Maione P,Rossi A,et al.Combined chemo-radiotherapy for locally advanced non-small cell lung cancer;current status and future development[J].Crit Rev Oncol Hematol,2008,68:2222-32.

    [4]Okamoto I.Overview of chemoradiation clinical trials for locally advanced non-small cell lung cancer in Japan[J].int J Clin Oncol,2008,13:112-116.

    [5]Juan o,sanchez-hemandez s,casal j,Full-dose cisplatin and oral vinorelbine concomitant with radiotherapy in unresectable stageIIInon-small cell lung cancer:amulti-center phaseIIstudy[J].anticancer res.2014;34(4):1959-66

    编辑/周芸霏, http://www.100md.com(闫立辉)
上一页1 2